[HTML][HTML] Early treatment with a combination of two potent neutralizing antibodies improves clinical outcomes and reduces virus replication and lung inflammation in …

KKA Van Rompay, KJ Olstad, RL Sammak… - PLoS …, 2021 - journals.plos.org
There is an urgent need for effective therapeutic interventions against SARS-CoV-2,
including new variants that continue to arise. Neutralizing monoclonal antibodies have …

[PDF][PDF] Early treatment with a combination of two potent neutralizing antibodies improves clinical outcomes and reduces virus replication and lung inflammation in …

KKA Van Rompay, KJ Olstad, RL Sammak… - PLoS …, 2021 - pdfs.semanticscholar.org
There is an urgent need for effective therapeutic interventions against SARS-CoV-2,
including new variants that continue to arise. Neutralizing monoclonal antibodies have …

[HTML][HTML] Early treatment with a combination of two potent neutralizing antibodies improves clinical outcomes and reduces virus replication and lung inflammation in …

KKA Van Rompay, KJ Olstad, RL Sammak… - PLoS …, 2021 - ncbi.nlm.nih.gov
There is an urgent need for effective therapeutic interventions against SARS-CoV-2,
including new variants that continue to arise. Neutralizing monoclonal antibodies have …

Early treatment with a combination of two potent neutralizing antibodies improves clinical outcomes and reduces virus replication and lung inflammation in SARS-CoV …

KKA Van Rompay, KJ Olstad, RL Sammak, J Dutra… - PLoS …, 2021 - go.gale.com
There is an urgent need for effective therapeutic interventions against SARS-CoV-2,
including new variants that continue to arise. Neutralizing monoclonal antibodies have …

Early treatment with a combination of two potent neutralizing antibodies improves clinical outcomes and reduces virus replication and lung inflammation in SARS-CoV …

KKA Van Rompay, KJ Olstad, RL Sammak… - PLoS …, 2021 - escholarship.org
There is an urgent need for effective therapeutic interventions against SARS-CoV-2,
including new variants that continue to arise. Neutralizing monoclonal antibodies have …

Early treatment with a combination of two potent neutralizing antibodies improves clinical outcomes and reduces virus replication and lung inflammation in SARS-CoV …

KKA Van Rompay, KJ Olstad, RL Sammak, J Dutra… - 2021 - agris.fao.org
There is an urgent need for effective therapeutic interventions against SARS-CoV-2,
including new variants that continue to arise. Neutralizing monoclonal antibodies have …

Early treatment with a combination of two potent neutralizing antibodies improves clinical outcomes and reduces virus replication and lung inflammation in SARS-CoV …

KKA Van Rompay, KJ Olstad, RL Sammak… - PLoS …, 2021 - pubmed.ncbi.nlm.nih.gov
There is an urgent need for effective therapeutic interventions against SARS-CoV-2,
including new variants that continue to arise. Neutralizing monoclonal antibodies have …

Early treatment with a combination of two potent neutralizing antibodies improves clinical outcomes and reduces virus replication and lung inflammation in SARS-CoV …

KKA Van Rompay, KJ Olstad, RL Sammak, J Dutra… - Plos …, 2021 - europepmc.org
There is an urgent need for effective therapeutic interventions against SARS-CoV-2,
including new variants that continue to arise. Neutralizing monoclonal antibodies have …

[PDF][PDF] Early treatment with a combination of two potent neutralizing antibodies improves clinical outcomes and reduces virus replication and lung inflammation in …

KKA Van Rompay, KJ Olstad, RL Sammak… - PLoS …, 2021 - scholar.archive.org
There is an urgent need for effective therapeutic interventions against SARS-CoV-2,
including new variants that continue to arise. Neutralizing monoclonal antibodies have …

Early treatment with a combination of two potent neutralizing antibodies improves clinical outcomes and reduces virus replication and lung inflammation in SARS-CoV …

KKA Van Rompay, KJ Olstad, RL Sammak… - PLoS …, 2021 - search.ebscohost.com
There is an urgent need for effective therapeutic interventions against SARS-CoV-2,
including new variants that continue to arise. Neutralizing monoclonal antibodies have …